Abiopharma

🔍 CULP H LAWRENCE JR (Director)

Company: GE HealthCare Technologies Inc. (GEHC)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 3,586 shares of Common Stock, par value $0.01 per share (Direct)
  Date: 2026-05-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 16,285.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 4,157 shares of Common Stock, par value $0.01 per share (Direct)
  Date: 2026-05-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 20,442.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock, par value $0.01 per share (Direct)
  Date: 2026-05-07 | Code: H | nature_of_ownership: By holding company | shares_owned_after: 151,207.00
• Holds 0 shares of Common Stock, par value $0.01 per share (Direct)
  Date: 2026-05-07 | Code: H | nature_of_ownership: By family trusts | shares_owned_after: 328,268.00

Footnotes:

• F1: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan").
• F2: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
• F3: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election.